NeuroPace, Inc. (NASDAQ:NPCE) Receives $15.67 Consensus Target Price from Analysts

NeuroPace, Inc. (NASDAQ:NPCE – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target […]

Related Keywords

United States ,Martha Morrell ,Leerink Partnrs ,Geode Capital Management ,Neuropace Company Profile ,Securities Exchange Commission ,Wells Fargo Company ,Citigroup Inc ,Barclays Plc ,Orbimed Advisors Llc ,Renaissance Technologies ,Susquehanna International Group ,Neuropace Inc ,Cantor Fitzgerald ,Nasdaq ,Get Free Report ,Street Capital ,Wells Fargo ,Exchange Commission ,International Group ,Capital Management ,Get Free ,Neuropace Daily ,